Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production.

Ähnliche Einträge

• Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use.
  von: Shimozato, T, et al.
  Veröffentlicht: (1990)
• Adenosine-Mediated Elevation of Cyclic 3′:5′-Adenosine Monophosphate Concentrations in Cultured Mouse Neuroblastoma Cells
  von: Blume, Arthur J., et al.
  Veröffentlicht: (1973)
• Cyclic adenosine monophosphate, CA++, and membranes.
  von: Rasmussen, H, et al.
  Veröffentlicht: (1968)
• Regulation of Adenosine 3′:5′-Cyclic Monophosphate Phosphodiesterase Activity in Fibroblasts by Intracellular Concentrations of Cyclic Adenosine Monophosphate
  von: D'Armiento, Massimo, et al.
  Veröffentlicht: (1972)
• The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice
  von: Hao, Huifeng, et al.
  Veröffentlicht: (2020)